[Elsevier] Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges

sujanrifat Post time 2024-5-10 00:55:07 | Show all posts |Read mode
Reward10points

journal£ºMetabolism

Authors£ºMichail Kokkorakis; Chrysoula Boutari; Michael A. Hill; Vasilios Kotsis; Rohit Loomba; Arun J. Sanyal; Christos S. Mantzoros

Published date£º2024-5-

DOI£º10.1016/j.metabol.2024.155835

PDF link£ºhttps://www.sciencedirect.com/sc ... 026049524000611/pdf

Article link£ºhttp://dx.doi.org/10.1016/j.metabol.2024.155835

Article Source£ºElsevier BV¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply3 Show all posts
Victor90 Post time 2024-5-10 00:55:08 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

chiralmatter Post time 2024-5-10 00:57:47 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

sujanrifat Post time 2024-5-10 01:00:00 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    10

Latest Reply

Return to the list